Slide

Participate in the BenfoTeam Study

The BenfoTeam clinical trial is taking place in approximately 40+ clinical trial sites in the U.S.

The BenfoTeam clinical trial is taking place in approximately 40+ clinical trial sites in the U.S.

The BenfoTeam clinical trial is taking place in approximately 40+ clinical trial sites in the U.S.

BenfoTeam tests if increasing thiamine in the blood slows cognitive decline in people with early Alzheimer’s disease, including Mild Cognitive Impairment (MCI) and mild dementia.

Participate in the BenfoTeam Study

The BenfoTeam clinical trial is taking place in approximately 40+ clinical trial sites in the U.S.

The BenfoTeam clinical trial is taking place in approximately 40+ clinical trial sites in the U.S.

The BenfoTeam clinical trial is taking place in approximately 40+ clinical trial sites in the U.S.

BenfoTeam tests if increasing thiamine in the blood slows cognitive decline in people with early Alzheimer’s disease, including Mild Cognitive Impairment (MCI) and mild dementia.

Participate in the BenfoTeam Study

The BenfoTeam clinical trial is taking place in approximately 40+ clinical trial sites in the U.S.

The BenfoTeam clinical trial is taking place in approximately 40+ clinical trial sites in the U.S.

The BenfoTeam clinical trial is taking place in approximately 40+ clinical trial sites in the U.S.

BenfoTeam tests if increasing thiamine in the blood slows cognitive decline in people with early Alzheimer’s disease, including Mild Cognitive Impairment (MCI) and mild dementia.

Slide
ADCS Logo

Combination Therapy Initiative

Currently accepting Letters of Intent to work with the ADCS to develop a grant application and clinical trial

Currently accepting Letters of Intent to work with the ADCS to develop a grant application and clinical trial

Currently accepting Letters of Intent to work with the ADCS to develop a grant application and clinical trial

Slide

Experiencing Memory Loss?

Learn if these are typical age-related or Alzheimer's-related symptoms

ADCS Logo
ADCS Logo

Learn if these are typical age-related
or Alzheimer's-related symptoms

Experiencing Memory Loss?

Learn if these are typical age-related or Alzheimer's-related symptoms

Experiencing Memory Loss?

ADCS Logo
Slide

Contribute to
Alzheimer's Disease Research

Contribute to Alzheimer's
Disease Research

Contribute to
Alzheimer's Disease Research

Join one of our clinical trials and help find a solution to memory loss

Join one of our clinical trials and help find a solution to memory loss

Join one of our clinical trials and help find a solution to memory loss

ADCS Logo
ADCS Logo
previous arrow
next arrow

Welcome to the ADCS at UC San Diego

The Alzheimer’s Disease Cooperative Study (ADCS) was formed in 1991 as a cooperative agreement between the National Institute on Aging (NIA) and the University of California, San Diego. The ADCS is a major initiative for Alzheimer’s disease (AD) clinical studies in the Federal Government, addressing treatments for both cognitive and behavioral symptoms. The ADCS is part of the NIA Division of Neuroscience’s effort to facilitate the discovery, development and testing of new drugs for the treatment of AD and is part of the Alzheimer’s Disease Prevention Initiative as well.

CURRENT ADCS STUDIES

VIVA-MIND Study


The VIVA-MIND trial is designed to determine if the study drug, varoglutamstat, can stabilize or slow memory and thinking problems that increase in early AD.

BenfoTeam Study


The BenfoTeam Study tests if increasing thiamine in the blood slows cognitive decline in people with early Alzheimer’s disease, including Mild Cognitive Impairment (MCI) and mild dementia.

Other Resources

  • UC San Diego Multi Modal Imaging Lab

  • UC San Diego Brain TV